Примери за използване на Immunological veterinary на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Annexed to the administrative data shall be copies of a document showing that the manufacturer is authorized to produce immunological veterinary medicinal products,
Member States shall take all appropriate measures to ensure that the manufacturing processess used in the manufacture of immunological veterinary medicinal products are completely validated
supply or use of immunological veterinary medicinal products on their territory
Member States should be able to allow under restricted conditions advertising of immunological veterinary medicinal products also to professional animal keepers.
The immunological veterinary medicinal product shall be administered at the recommended dose
enabling the competent authority to verify that the immunological veterinary medicinal product is in accordance with its formula after it has been placed on the market.
competent authorities may require the marketing authorisation holder for immunological veterinary medicinal products to submit to the competent authorities the copies of all the control reports signed by the qualified person in accordance with Article 101.
Member States may require the marketing authorization holder for immunological veterinary medicinal products to submit to the competent authorities copies of all the control reports signed by the qualified person in accordance with Article 55.
Member States may provide that this Directive shall not apply to non-inactivated immunological veterinary medicinal products which are manufactured from pathogens
AVs should be defined as: inactivated immunological veterinary medicinal products which are manufactured from pathogens
the control shall repeat, on the samples provided, all the tests carried out by the manufacturer on the finished immunological veterinary medicinal product, in accordance with the relevant specifications in its dossier for marketing authorisation.
Inactivated immunological veterinary medicinal products referred to in Article 2(3) shall only be used in the animals referred to therein in exceptional circumstances, in accordance with a veterinary prescription, and if no immunological veterinary medicinal product is authorised for the target animal species
under the centralised procedure, of its intention to control batches of the immunological veterinary medicinal product.
the Secretary of State may permit the administration to that animal of an immunological veterinary medicinal product that is not covered by a marketing authorisation in the United Kingdom
The marketing authorization holder for immunological veterinary medicinal products shall ensure that an adequate number of representative samples of each batch of veterinary medical products is held in stock at least up to the expiry date, and provide samples promptly to the competent authorities on request.
a Member State may require the marketing authorisation holder for an immunological veterinary medicinal product to submit samples of batches of the bulk product and/or veterinary medicinal product for control by an Official Medicines Control Laboratory before the product is put into circulation.
a competent authority may allow the use of an immunological veterinary medicinal product not authorised within the Union.
in that third country, a competent authority may permit the use, solely for the animal in question, of an immunological veterinary medicinal product that is not covered by a marketing authorisation in the Member State in question but its use is
a competent authority may require the holder of a marketing authorisation for an immunological veterinary medicinal product to submit samples of batches of the bulk product or of the immunological veterinary medicinal product for control by an Official Medicines Control Laboratory before the product is placed on the market.
a competent authority may permit the use, solely for the animal in question, of an immunological veterinary medicinal product that is not covered by a marketing authorisation in the Member State in question